首页 › 基金 › Integral Health Asset Management, LLC › REGN
Integral Health Asset Management, LLC 对 REGN 的持仓历史
REGENERON PHARMACEUTICALS · 医疗保健
Integral Health Asset Management, LLC 在 Q3 2026 的 13F 申报中披露持有 REGN(REGENERON PHARMACEUTICALS)40,000 股,市值约 US$30.3M,约占其申报组合的 1.97%,在其申报持仓中市值排名第 11 位。 Integral Health Asset Management, LLC 最近 12 个申报季度中有 8 个季度披露了 REGN 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Integral Health Asset Management, LLC 对 REGN 的持仓演变
Integral Health Asset Management, LLC 于 Q4 2023 首次披露 REGN 持仓:25,000 股(约 US$22.0M)。 该持仓在 Q4 2025 达到峰值 105,000 股,市值约 US$81.0M。 在 8 次申报中,Integral Health Asset Management, LLC 1 次增持、3 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 40,000 股、市值约 US$30.3M。 持仓曾出现大幅变动:Q1 2024 减持约 32% (随后一个季度股价上涨 9%)、Q4 2025 增持约 110% (随后一个季度股价基本持平)、Q2 2026 减持约 53% (随后一个季度股价上涨 22%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 25.00K | $21.96M | 新进 |
| Q1 2024 | 17.00K | $16.36M | 减持 |
| Q2 2025 | 50.00K | $26.25M | 新进 |
| Q3 2025 | 50.00K | $28.11M | 持有 |
| Q4 2025 | 105.00K | $81.05M | 增持 |
| Q1 2026 | 85.00K | $65.67M | 减持 |
| Q2 2026 | 40.00K | $24.94M | 减持 |
| Q3 2026 | 40.00K | $30.33M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 REGN 与 13F 数据
REGN(REGENERON PHARMACEUTICALS)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 REGN,申报仓位最大的包括:DODGE & COX (US$3.62B), Dodge & Cox (US$3.04B), 富兰克林资源 (US$2.75B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 REGN 的基金
- DODGE & COX 4.77M 股 · $3.62B · Q3 2026
- Dodge & Cox 4.87M 股 · $3.04B · Q2 2026
- 富兰克林资源 2.95M 股 · $2.75B · Q3 2026
- Nuveen, LLC 1.96M 股 · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M 股 · $1.30B · Q3 2026
更多关于 Integral Health Asset Management, LLC
常见问题
How long has Integral Health Asset Management, LLC held REGN?
Integral Health Asset Management, LLC has disclosed REGN holdings in 8 of the last 12 reported quarters, going back to Q4 2023.
What is Integral Health Asset Management, LLC's current position in REGN?
As of Q3 2026, Integral Health Asset Management, LLC holds 40.00K shares of REGN (REGENERON PHARMACEUTICALS), valued at $30.33M, representing 1.97% of its reported portfolio and ranking #11.
Has Integral Health Asset Management, LLC been buying or selling REGN?
In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC held unchanged its position in REGN. The position peaked in Q4 2025 at 105.00K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include DODGE & COX, Dodge & Cox, 富兰克林资源, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.